Last week, the EU was a bad conclusion about Astrazeneca, this week, they received bad news about Johnson & Johnson's vaccine.

The British Authority and the European Union Health Agency (EU) between the previous week determine the coagulation is a very rare side effect of Astrazeneca vaccine.

Pfizer-biontech vaccination nurse for a person sitting on the car in France on April 13.

European officials are confident that they have ensured enough vaccine instead of Astrazeneca and will achieve full vaccination goals for 70% of the EU mature population, about 255 million people, at the end of the summer

The EU put hope at least 300 million doses expected to be moved to the next three months, two-thirds of which from Pfizer, the company often delivers on time.

Trouble with two types of vaccines covering the ball on the EU vaccination campaign, at the time they are accelerating after months of shortage supply and meet logistics issues.

The whole EU still injects Astrazeneca vaccine for the elderly, but some countries have different regulations when using it for younger people.

This is in contrast to the initial recommendations when the new Astrazeneca vaccine is implemented.

According to a poll was announced last month, 61% of the French, 55% of Germans and 52% of Spanish considering the Astrazeneca vaccine was "unsafe".

Managers have asked vaccines and doctors to prevent certain symptoms, including intense, persistent headaches and small bleeding nodules under the skin.

In Poland, where the vaccination campaign is mainly based on Astrazeneca and has not yet released the use of this vaccine, a recent poll shows if it is selected, less than 5% of Poles choose to inject Astrazeneca.

Across the EU, many people want to find replacement vaccines like Moderna and Pfizer.

However, it is difficult to predict the impact of troubles around the Vaccine Astrazeneca and Johnson & Johnson with how big the EU immunization efforts will be, when officials in Brussels have tried to enhance supply in the quarter.

The EU expects to receive at least 300 million doses of vaccines, three times the level they received in the first quarter, including 200 million doses of Pfizer-Biontech, 35 million doses of Moderna, 55 million doses of Johnson & Johnson and 70 million doses of Astrazeneca.

In the middle of the week before, after the Spanish government changed the limit of Astrazeneca injection age, two-thirds of people with vaccination schedule in Madrid did not arrive in an appointment, local health official Antonio Zapatero said.

At Alpes-Maritimes in southern France, where are often considered one of the most vaccinated countries in Europe, pharmacists say many people who come to Vaccine Covid-19 have declined after knowing the type

In Belgium, where the use of Astrazeneca vaccines is also limited, officials believe that the vaccination campaign will not slow down much, but they are still concerned about the blood-free effects.

Yves van laethem, a leading epidemiologist who spoken by Belgium's anti-Covid-19 team, predicted that the vaccine troubles made the vaccination campaign stalled for two weeks, will affect mainly to the

The European Pharmaceutical Agency did not give clear opinions and it was also part of the problem, Van Laethem said.

Although the EU distributes members of many vaccines that the approved block includes Astrazeneca, Johnson & Johnson, Moderna and Pfizer, many countries have originally given up the Pfizer and Moderna sections divided by more Astrazeneca vaccines, due to

"In England or Eastern Europe, most of the vaccination campaigns are based on Astrazeneca," Van Laethem said.

The more richer members in the block like Denmark, France, Germany and the Netherlands can offset the public to lose faith in Astrazeneca, because they bought more vaccines from other sources, especially Pfizer, from the countries

Van Laethem said that EU officials and countries need to better assess the benefits and harms of using Astrazeneca compared to other types.

"It is important to make people understand that the problem is virus," he said.